December 29, 2021
With the Omicron variant of COVID-19 surging through the country, access to timely testing is becoming a major constraint to heading off the surge. The White House announced new measures to make at-home tests more readily available beginning in January. Unfortunately, a lot of questions remain as to how health insurers will pay for the over-the-counter tests. USA Today recently spoke with Rena Conti, Associate Professor of Markets, Public Policy, & Law to discuss the issues surrounding barriers to access.
“If consumers face out-of-pocket costs, even if they’re relatively cheap, the likelihood is that they won’t use the tests.”Rena Conti
Associate Professor of MARKETS, PUBLIC POLICY, & LAW
- [The Economist] The Warm Glow
- ESG Investing Isn’t Designed to Save the Planet
- [Time] What Happens When Kids Learn That Racism Can’t Be Overcome
- [Boston Business Journal] Best Bang for the Buck
- [Techround] StartUp of the Week: Wisdomise
- Epinephrine Autoinjector Costs Remain High for Some Patients with Private Insurance
- Food Delivery Platforms: Worth the Bite Out of Revenue for Restaurants, or has the Relationship Spoiled?
- How PayPal Gets Employees Invested in Innovation
- [Forbes] How Boris Johnson Managed His Crises Provides Key Lessons For Business Leaders
- [FanBuzz] Study Finds that Experienced, Older Male Umpires are Actually the Worst-Performing in Major League Baseball